ProQR, Galapagos in oligonucleotide deal for fibrosis

ProQR Therapeutics N.V. (NASDAQ:PRQR) and Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG)

Read the full 98 word article

User Sign In